- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Par Drugs and Chemicals Ltd (PARR)
Par Drugs and Chemicals Ltd stock price live, this page displays NSE PARR stock exchange data. View the PARR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Par Drugs and Chemicals Ltd real time stock price chart below.
What Is the Par Drugs and Chemicals Ltd Stock Price Today?
The Par Drugs and Chemicals Ltd stock price today is 100.98.
What Is the Stock Symbol for Par Drugs and Chemicals Ltd?
The stock symbol for Par Drugs and Chemicals Ltd is ""PARR.""
What Stock Exchange Does Par Drugs and Chemicals Ltd Trade On?
Par Drugs and Chemicals Ltd is listed and trades on the NSE stock exchange.
Is Par Drugs and Chemicals Ltd a Good Stock to Buy?
Determining whether Par Drugs and Chemicals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PARR quote. (ISIN: INE04LG01015)
What Is the Par Drugs and Chemicals Ltd Stock Price Today?
The Par Drugs and Chemicals Ltd stock price today is 100.98.
What Is the Stock Symbol for Par Drugs and Chemicals Ltd?
The stock symbol for Par Drugs and Chemicals Ltd is ""PARR.""
What Stock Exchange Does Par Drugs and Chemicals Ltd Trade On?
Par Drugs and Chemicals Ltd is listed and trades on the NSE stock exchange.
Is Par Drugs and Chemicals Ltd a Good Stock to Buy?
Determining whether Par Drugs and Chemicals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PARR quote. (ISIN: INE04LG01015)
NSE
Currency in INR
100.98
+1.98(+2.00%)
Closed·
Fair Value
An estimate of a Par Drugs's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
100.98
100.98
52 wk Range
81.01
348.45
PARR Scorecard
Full Analysis
Valuation implies a strong free cash flow yield
PARR is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Par Drugs's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
100.98100.98
52 wk Range
81.01348.45
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
PARR Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Par Drugs's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Par Drugs and Chemicals Ltd Company Profile
Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, magnesium aluminometasilicate, magnesium aluminosilicate-USP, magnesium oxide light, magnesium oxide heavy, magnesium aluminium hydrate, hydrotalcite, and synthetic aluminium silicate. It offers fine chemicals, such as precipitated silica, sodium aluminium silicate, amorphous aluminium hydroxide, PARSIL-HT, PAR ADD OP, MagSil OF, FlowSil, aluminium hydroxide magnesium carbonate co-dried gel, magnesium aluminium silicate hydrated (pharma), and magnesium aluminium silicate hydrated (agro). It exports its products to Germany, the United Kingdom, Bangladesh, Iran, the United Arab Emirates, Indonesia, Japan, South Korea, and internationally. Par Drugs and Chemicals Limited was founded in 1982 and is based in Vadodara, India.
Compare PARR to Peers and Sector
Metrics to compare | PARR | Peers Peers - average of corresponding metrics from companies closely matching PARR: 538634, SHILPAMED, AARTIDRUGS, 540694, ACCENTMIC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPARRPeersSector |
|---|---|---|---|---|
P/E Ratio | 8.8x | 11.9x | −0.5x | |
PEG Ratio | −3.16 | 0.11 | 0.00 | |
Price/Book | 1.3x | 1.2x | 2.6x | |
Price / LTM Sales | 1.2x | 0.8x | 3.3x | |
Upside (Analyst Target) | - | 22.4% | 43.5% | |
Fair Value Upside | Unlock | 11.3% | 6.8% | Unlock |
Earnings
Latest Release
May 15, 2025
EPS / Forecast
1.34 / --
Revenue / Forecast
231.19M / --
People Also Watch
FAQ
What Stock Exchange Does Par Drugs Trade On?
Par Drugs is listed and trades on the India National Stock Exchange stock exchange.
What Is the Stock Symbol for Par Drugs?
The stock symbol for Par Drugs is "PARR."
What Is the Par Drugs Market Cap?
As of today, Par Drugs market cap is 1.24B.
What Is Par Drugs's Earnings Per Share (TTM)?
The Par Drugs EPS (TTM) is 11.50.
From a Technical Analysis Perspective, Is PARR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Par Drugs Stock Split?
Par Drugs has split 1 times.
How Many Employees Does Par Drugs Have?
Par Drugs has 122 employees.
What is the current trading status of Par Drugs (PARR)?
As of 09 Aug 2025, Par Drugs (PARR) is trading at a price of 100.98, with a previous close of 99.00. The stock has fluctuated within a day range of 100.98 to 100.98, while its 52-week range spans from 81.01 to 348.45.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.